Browsing by Author Heller, Simon

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2012Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsChalmers, John; Colagiuri, Stephen; Fulcher, Greg; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, M; de Galan, B; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Li, Q; MacMahon, Stephen; Marre, Michel; Ninomiya, T; Poulter, Neil; Travert, F; Zoungas, Sophia; The George Institute for Global Health; Central Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthAssociation of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 3, 2012,pp 636-643
2009Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialAnderson, Craig; Chalmers, John; de Galan, Bastiaan; Hackett, Maree; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Dufouil, C; Grobbee, D; Hamet, Pavel; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Pan, C; Poulter, N.; Travert, F; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthCognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.52, 11,pp 2328-2336
2009The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCEChalmers, John; de Galan, Bastiaan; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Grobbee, Diederick; Hamet, Pavel; Heller, Simon; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE, Diabetes Care, vol.32, 11,pp 2068-2074
2011Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trialChalmers, John; Neal, Bruce; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Heller, Simon; Januszewicz, Andrzej; Joshi, Prashant; Liu, Lisheng; Pan, C; Poulter, Neil; Tandon, Nikhil; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthDoes Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial, Diabetes Care, vol.34, 12, 2011,pp 2491-2495
2009Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetesBillot, Laurent; Bompoint, Severine; Chalmers, John; de Galan, Bastiaan; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; Glasziou, Paul; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Pan, C; Poulter, Neil; Rodgers, Anthony; Travert, F; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthEffects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2009,pp 2560-2572
2014Follow-up of blood-pressure lowering and glucose control in type 2 diabetesArima, Hisatomi; Billot, Laurent; Chalmers, John; Colagiuri, Stephen; Hirakawa, Yoichiro; Joshi, Rohina; Li, Qiang; MacMahon, Stephen William; Monaghan, Helen; Neal, Bruce; Patel, Anushka; Perkovic, Vlado; Rodgers, Anthony; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; et al, Various; Glasziou, Paul P; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Marre, Michel; Matthews, David. R.; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthFollow-up of blood-pressure lowering and glucose control in type 2 diabetes, The New England Journal of Medicine, vol.371, 15, 2014,pp 1392-1406
2010The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: PreteraxChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Woodward, Mark; Grobbee, Diederick E.; Hamet, Pavel; Heller, Simon; Marre, Michel; Pan, C; Zoungas, Sophia; The George Institute for International Health; Central Clinical School: Medicine; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 5,pp 821-831
2014Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesChalmers, John; Li, Qiang; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Marre, Michel; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthImpact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes, Diabetologia, vol.57, 12, 2014,pp 2465-2474
2014Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Van Dieren, Susan; Woodward, Mark; Zoungas, Sophia; Beulens, Joline W. J.; Davis, T. M. E.; Fulcher, Greg R.; Hamet, Pavel; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Peelen, Linda; van der Schouw, Yvonne T; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthIntensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial, Diabetes, Obesity and Metabolism, vol.16, 5, 2014,pp 426-432
2008Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesBillot, Laurent; Chalmers, John; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; et, al; Glasziou, Paul; Grobbee, Diederick; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2008,pp 2560-2572
2016Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONChalmers, John; Li, Qiang; MacMahon, Stephen William; Neal, Bruce; Perkovic, Vlado; Rodgers, Anthony; Wong, Muh Geot; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Matthews, David; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthLong-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON, Diabetes Care, vol.39, 5, 2016,pp 694-700
2017Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition usedChen, Roger; Heller, Simon; Jaeckel, Elmar; Jarlov, Henrik; Lehmann, Lucine; Lingvay, Ildiko; Norwood, Paul; Concord Clinical School: MedicineRates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used, Diabetes, Obesity and Metabolism, vol.19, 11, 2017,pp 1562-1569
2010Severe hypoglycemia and risks of vascular events and deathBillot, Laurent; Chalmers, John; de Galan, Bastiaan; Kengne, Andre; Li, Qiang; MacMahon, Stephen; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Grobbee, Diederick; Heller, Simon; Marre, Michel; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthSevere hypoglycemia and risks of vascular events and death, New England Journal of Medicine, vol.363, 15,pp 1410-1418